A mRNA-Responsive G-Quadruplex-Based Drug Release System

G-quadruplex-based drug delivery carriers (GDDCs) were designed to capture and release a telomerase inhibitor in response to a target mRNA. Hybridization between a loop on the GDDC structure and the mRNA should cause the G-quadruplex structure of the GDDC to unfold and release the bound inhibitor, a...

Full description

Bibliographic Details
Main Authors: Hidenobu Yaku, Takashi Murashima, Daisuke Miyoshi, Naoki Sugimoto
Format: Article
Language:English
Published: MDPI AG 2015-04-01
Series:Sensors
Subjects:
Online Access:http://www.mdpi.com/1424-8220/15/4/9388
_version_ 1828153829131026432
author Hidenobu Yaku
Takashi Murashima
Daisuke Miyoshi
Naoki Sugimoto
author_facet Hidenobu Yaku
Takashi Murashima
Daisuke Miyoshi
Naoki Sugimoto
author_sort Hidenobu Yaku
collection DOAJ
description G-quadruplex-based drug delivery carriers (GDDCs) were designed to capture and release a telomerase inhibitor in response to a target mRNA. Hybridization between a loop on the GDDC structure and the mRNA should cause the G-quadruplex structure of the GDDC to unfold and release the bound inhibitor, anionic copper(II) phthalocyanine (CuAPC). As a proof of concept, GDDCs were designed with a 10-30-mer loop, which can hybridize with a target sequence in epidermal growth factor receptor (EGFR) mRNA. Structural analysis using circular dichroism (CD) spectroscopy showed that the GDDCs form a (3 + 1) type G-quadruplex structure in 100 mM KCl and 10 mM MgCl2 in the absence of the target RNA. Visible absorbance titration experiments showed that the GDDCs bind to CuAPC with Ka values of 1.5 × 105 to 5.9 × 105 M−1 (Kd values of 6.7 to 1.7 μM) at 25 °C, depending on the loop length. Fluorescence titration further showed that the G-quadruplex structure unfolds upon binding to the target RNA with Ka values above 1.0 × 108 M−1 (Kd values below 0.01 μM) at 25 °C. These results suggest the carrier can sense and bind to the target RNA, which should result in release of the bound drug. Finally, visible absorbance titration experiments demonstrated that the GDDC release CuAPC in response to the target RNA.
first_indexed 2024-04-11T22:30:46Z
format Article
id doaj.art-03dc2d20de0740a1bbeaa2ccf060303e
institution Directory Open Access Journal
issn 1424-8220
language English
last_indexed 2024-04-11T22:30:46Z
publishDate 2015-04-01
publisher MDPI AG
record_format Article
series Sensors
spelling doaj.art-03dc2d20de0740a1bbeaa2ccf060303e2022-12-22T03:59:24ZengMDPI AGSensors1424-82202015-04-011549388940310.3390/s150409388s150409388A mRNA-Responsive G-Quadruplex-Based Drug Release SystemHidenobu Yaku0Takashi Murashima1Daisuke Miyoshi2Naoki Sugimoto3Advanced Research Division, Panasonic Corporation, 3-4 Hikaridai, Seika-cho, Soraku-gun, Kyoto 619-0237, JapanFaculty of Frontiers of Innovative Research in Science and Technology (FIRST), Konan University, 7-1-20 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, JapanFaculty of Frontiers of Innovative Research in Science and Technology (FIRST), Konan University, 7-1-20 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, JapanFaculty of Frontiers of Innovative Research in Science and Technology (FIRST), Konan University, 7-1-20 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, JapanG-quadruplex-based drug delivery carriers (GDDCs) were designed to capture and release a telomerase inhibitor in response to a target mRNA. Hybridization between a loop on the GDDC structure and the mRNA should cause the G-quadruplex structure of the GDDC to unfold and release the bound inhibitor, anionic copper(II) phthalocyanine (CuAPC). As a proof of concept, GDDCs were designed with a 10-30-mer loop, which can hybridize with a target sequence in epidermal growth factor receptor (EGFR) mRNA. Structural analysis using circular dichroism (CD) spectroscopy showed that the GDDCs form a (3 + 1) type G-quadruplex structure in 100 mM KCl and 10 mM MgCl2 in the absence of the target RNA. Visible absorbance titration experiments showed that the GDDCs bind to CuAPC with Ka values of 1.5 × 105 to 5.9 × 105 M−1 (Kd values of 6.7 to 1.7 μM) at 25 °C, depending on the loop length. Fluorescence titration further showed that the G-quadruplex structure unfolds upon binding to the target RNA with Ka values above 1.0 × 108 M−1 (Kd values below 0.01 μM) at 25 °C. These results suggest the carrier can sense and bind to the target RNA, which should result in release of the bound drug. Finally, visible absorbance titration experiments demonstrated that the GDDC release CuAPC in response to the target RNA.http://www.mdpi.com/1424-8220/15/4/9388drug delivery carrierG-quadruplexanionic phthalocyaninecancermRNAtelomerase
spellingShingle Hidenobu Yaku
Takashi Murashima
Daisuke Miyoshi
Naoki Sugimoto
A mRNA-Responsive G-Quadruplex-Based Drug Release System
Sensors
drug delivery carrier
G-quadruplex
anionic phthalocyanine
cancer
mRNA
telomerase
title A mRNA-Responsive G-Quadruplex-Based Drug Release System
title_full A mRNA-Responsive G-Quadruplex-Based Drug Release System
title_fullStr A mRNA-Responsive G-Quadruplex-Based Drug Release System
title_full_unstemmed A mRNA-Responsive G-Quadruplex-Based Drug Release System
title_short A mRNA-Responsive G-Quadruplex-Based Drug Release System
title_sort mrna responsive g quadruplex based drug release system
topic drug delivery carrier
G-quadruplex
anionic phthalocyanine
cancer
mRNA
telomerase
url http://www.mdpi.com/1424-8220/15/4/9388
work_keys_str_mv AT hidenobuyaku amrnaresponsivegquadruplexbaseddrugreleasesystem
AT takashimurashima amrnaresponsivegquadruplexbaseddrugreleasesystem
AT daisukemiyoshi amrnaresponsivegquadruplexbaseddrugreleasesystem
AT naokisugimoto amrnaresponsivegquadruplexbaseddrugreleasesystem
AT hidenobuyaku mrnaresponsivegquadruplexbaseddrugreleasesystem
AT takashimurashima mrnaresponsivegquadruplexbaseddrugreleasesystem
AT daisukemiyoshi mrnaresponsivegquadruplexbaseddrugreleasesystem
AT naokisugimoto mrnaresponsivegquadruplexbaseddrugreleasesystem